In Vitro–Deranged Intestinal Immune Response to Gliadin in Type 1 Diabetes
- Renata Auricchio1,
- Francesco Paparo1,
- Maria Maglio1,
- Adriana Franzese1,
- Francesca Lombardi1,
- Giuliana Valerio1,
- Gerardo Nardone2,
- Selvaggia Percopo1,
- Luigi Greco1 and
- Riccardo Troncone1
- 1Department of Pediatrics and European Laboratory for the Investigation of Food-Induced Diseases, University “Federico II,” Naples, Italy
- 2Department of Experimental Medicine, University “Federico II,” Naples, Italy
- Address correspondence and reprint requests to Dr. Renata Auricchio, Dipartimento di Pediatria, Università Federico II, via Sergio Pansini 5, I-80131 Napoli, Italy. E-mail: reauricc{at}tin.it
Abstract
Dietary gluten has been associated with an increased risk of type 1 diabetes. We have evaluated inflammation and the mucosal immune response to gliadin in the jejunum of patients with type 1 diabetes. Small intestinal biopsies from 17 children with type 1 diabetes without serological markers of celiac disease and from 50 age-matched control subjects were examined by immunohistochemistry. In addition, biopsies from 12 type 1 diabetic patients and 8 control subjects were cultured with gliadin or ovalbumin peptic-tryptic digest and examined for epithelial infiltration and lamina propria T-cell activation. The density of intraepithelial CD3+ and γδ+ cells and of lamina propria CD25+ mononuclear cells was higher in jejunal biopsies from type 1 diabetic patients versus control subjects. In the patients’ biopsies cultured with peptic-tryptic gliadin, there was epithelial infiltration by CD3+ cells, a significant increase in lamina propria CD25+ and CD80+ cells and enhanced expression of lamina propria CD54 and crypt HLA-DR. No such phenomena were observed in control subjects, even those with celiac disease–associated HLA haplotypes. In conclusion, signs of mucosal inflammation were present in jejunal biopsies from type 1 diabetic patients, and organ culture studies indicate a deranged mucosal immune response to gliadin.
Footnotes
-
- Accepted March 19, 2004.
- Received July 29, 2003.
- DIABETES














